Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: Data from the Women's Genome Health Study

American Heart Journal

Volumn 157, Issue 4, 2009, Pages

  Albert, Michelle A ^a   Pare, Guillaume ^a   Morris, Alanna ^a   Rose, Lynda ^a   Buring, Julie ^a   Ridker, Paul M ^a   Zee, Robert Y L ^a  

^a Division of Cardiovascular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIOLOGICAL MARKER; FIBRINOGEN; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HISPANIC; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 63149151261     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.12.012     Document Type: Article

References (38)

1. Rosamond W., Flegal K., Furie K., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics 2008 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Burke A., et al. Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks. Circulation 105 (2002) 419-424
3. Strong J.P., Oalmann M.C., Newman III W.P., et al. Coronary heart disease in young black and white males in New Orleans: Community Pathology Study. Am Heart J 108 (1984) 747-759
4. Tang W., Detrano R.C., Brezden O.S., et al. Racial differences in coronary calcium prevalence among high-risk adults. Am J Cardiol 75 (1995) 1088-1091
5. Jain T., Peshock R., McGuire D.K., et al. African Americans and Caucasians Have a Similar Prevalence of Coronary Calcium in the Dallas Heart Study. J Am Coll Cardiol 44 (2004) 1011-1017
6. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in c-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469
7. Albert M.A., Glynn R.J., Buring J., et al. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93 (2004) 1238-1242
8. Albert M.A., Glynn R.J., Buring J.E., et al. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol 99 (2007) 1246-1251
9. Cook D.G., Cappuccio F.P., Atkinson R.W., et al. Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene. Am J Epidemiol 153 (2001) 799-806
10. Folsom A.R., Nieto F.J., McGovern P.G., et al. Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 98 (1998) 204-210
11. Markus H., Kapozsta Z., Ditrich R., et al. Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms. Stroke 32 (2001) 2465-2471
12. Ridker P.M., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
13. Lee I.M., Cook N.R., Gaziano J.M., et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294 (2005) 56-65
14. Ridker P.M., Chasman D., Zee R., et al. Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More than 25,000 Initially Healthy American Women. Clin Chem 54 (2008) 249-255
15. Cheng S., Grow M.A., Pallaud C., et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9 (1999) 936-949
16. Fibrinogen Studies Collaboration. Association of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies Collaboration. Am J Epidemiol 166 (2007) 867-879
17. Morgan T.M., Krumholtz H.M., Lifton R.P., et al. Nonvalidation of Reported Genetic Risk Factors for Acute coronary Syndrome in a Large-Scale Replication Study. JAMA 297 (2007) 1551-1561
18. de Matt M.P. Effects of Diet, Drugs, and Genes on Plasma Fibrinogen Levels. Ann N Y Acad Sci 936 (2001) 509-521
19. Humphries S.E., Ye S., Talmud P., et al. European Atherosclerosis Research Study: Genotype at the fibrinogen locus (g-455-a beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for Gender-Genotype-Environment Interaction. Arterioscler Thromb Vasc Biol 15 (1995) 96-104
20. Reiner A.P., Carty C.L., Carlson C.S., et al. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: The Coronary Artery Risk in young Adults (CARDIA) Study. J Thromb Haemost 4 (2006) 1279-1287
21. Folsom A.R., Qamheih H.T., Flack J.M., et al. Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk in young Adults (CARDIA) Study. Am J Epidemiol 138 (1993) 1023-1036
22. Gangi V., and Kafai M.R. Demographic, health lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 77 (2003) 826-833
23. Sacco R.L., Anand K., Lee H.S., et al. Homocysteine and the risk of ischemic stroke in a Triethnic Cohort the Northern Manhattan Study. Stroke 35 (2004) 2263-2269
24. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
25. Stevenson R.E., Schwartz C.E., Du Y.Z., et al. Differences in methylenetetrahydrofolate reductase genotype frequencies, between whites and blacks. Am J Hum Genet 60 (1997) 229-230
26. McAndrew P.E., Brandt J.T., Pearl D.K., et al. The incidence of the gene for the thermolabile methylene tetrahydrofolate reductase in African-Americans. Thromb Res 83 (1996) 195-198
27. Zee R.Y., Mora S., Cheng S., et al. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677c>t polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem 53 (2007) 845-851
28. Brugada R., and Marian A.J. A common mutation in methlenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Atherosclerosis 128 (1997) 107-112
29. Dilley A., Hooper W.C., El-Jamil M., et al. Mutations in the genes regulating methylene tertahydrofolate reductase (mthfr càt677) and cystathione beta-synthase (cbs gàa919, dbs tàc833) are not associated with myocardial infraction in African Americans. Thromb Res 103 (2001) 109-115
30. Sosin M.D., Patel J.V., Bhatia G.S., et al. Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure. Int J Cardiol 129 (2008) 69-75
31. Cappuccio F.P., Bell R., Perry I.J., et al. Homocysteine levels in men and women of different ethnic and cultural background living in England. Atherosclerosis 164 (2002) 95-102
32. Zee R.Y., Cheng S., Eelich H.A., et al. Intercellular adhesion molecule 1 (icam1) lys56met and gly241arg gene variants, plasma-soluble icam1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women. Stroke 38 (2007) 3152-3157
33. Albert M.A., Glynn R.J., Buring J.E., et al. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compares to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis 197 (2008) 292-302
34. Zimmerman P.A., Wieseman M., Spalding T., et al. A new intercellular adhesion molecule-1 allele identified in West Africans is prevalent in African-Americans in contrast to other North-American racial groups. Tissue Antigens 50 (1997) 654-656
35. Bielinski S.J., pankow J.S., Li N., et al. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM:1: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 201 (2008) 339-344
36. Fernandez-Reyes D., Craig A.G., Kyes S.A., et al. A high frequency African Coding polymorphism in the n-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 6 (1997) 1357-1360
37. Register T.C., Burdon K.P., Kenchik L., et al. Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. Clin Chem 50 (2004) 2185-2187
38. Ridker P.M., Pare G., Parker A., et al. Loci related to metabolic syndrome pathways including LEPR, HNF1A, IL6R and GCKR associate with plasma C-reactive protein: The Women's Genome Health Study. Am J Hum Genet 82 (2008) 1185-1192